Overview

Movicol in Childhood Constipation (ProMotion Study)

Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
This was a single centre study comprised of two stages (Parts I and II). Part I was a 9-day open label evaluation of Movicol administered to patients in hospital. This study evaluated the safety and efficacy of Movicol in treating faecal impaction. Movicol was administered over 3 - 7 days to achieve disimpaction.
Phase:
Phase 2
Details
Lead Sponsor:
Norgine
Treatments:
Lactulose
Polyethylene glycol 3350